Pharmacogenomic strategies against resistance development in microbial infections

Author： Ziebuhr Wilma Xiao Ke Coulibaly Boubacar Schwarz Roland Dandekar Thomas

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.5, Iss.4, 2004-06, pp. : 361-379

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacogenomic strategies against microbial resistance: from bright to bleak to innovative

By Dandekar Thomas Dandekar Gudrun

Pharmacogenomics, Vol. 11, Iss. 9, 2010-09 ,pp. : 1193-1196

Future Medicine

Access to resources Recommend Favorite

Parenteral Antibiotic Therapy in the Treatment of Lower Respiratory Tract Infections. Strategies to Minimize the Development of Antibiotic Resistance

By Cazzola M. Matera M.G. Noschese P.

Pulmonary Pharmacology & Therapeutics, Vol. 13, Iss. 6, 2000-12 ,pp. : 249-256

Academic Press

Access to resources Recommend Favorite

Sphingolipids as Targets for Microbial Infections

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 6, 2006-06 ,pp. : 671-680

Bentham Science Publishers

Access to resources Recommend Favorite

Current pharmacogenomic approaches to clinical drug development

By Murphy Michael P

Pharmacogenomics, Vol. 1, Iss. 2, 2000-05 ,pp. : 115-123

Future Medicine

Access to resources Recommend Favorite

Perspectives on development of a combination pharmacogenomic diagnostic and drug product

By McCamish Mark Izumi Raquel

Pharmacogenomics, Vol. 7, Iss. 7, 2006-10 ,pp. : 1045-1049

Future Medicine

Access to resources Recommend Favorite